142 studies found for:    Open Studies | "Lupus Erythematosus, Systemic"
Show Display Options
Rank Status Study
21 Recruiting RSLV-132 Biologic Proof-of-Concept in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: RSLV-132
22 Recruiting Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
Conditions: Antiphospholipid Syndrome;   Thrombophilia Due to Antiphospholipid Antibody;   Systemic Lupus Erythematosus
Intervention: Other: Phlebotomy
23 Recruiting GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Belimumab;   Drug: Placebo
24 Unknown  Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan
Conditions: Rheumatoid Arthritis;   Systemic Lupus Erythematosus;   Ankylosing Spondylitis
Intervention:
25 Recruiting Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
26 Not yet recruiting A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
Condition: Systemic Lupus Erythematosus
Interventions: Drug: CC-220;   Drug: Placebo
27 Recruiting BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Belimumab
28 Recruiting A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Tabalumab Auto-Injector;   Drug: Tabalumab Prefilled Syringe
29 Recruiting Systemic Lupus Erythematosus in Gullah Health
Condition: Systemic Lupus Erythematosus
Intervention:
30 Not yet recruiting Nelfinavir in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Nelfinavir
31 Recruiting Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Allogeneic Stem Cell Transplantation
32 Recruiting Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Hematopoietic stem cell transplantation
33 Unknown  Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease
Condition: Systemic Lupus Erythematosus
Intervention: Drug: quinipril
34 Recruiting A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Cyclophosphamide
35 Recruiting Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: human umbilical cord derived MSC transplantation for SLE
36 Recruiting Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus.
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Cholecalciferol;   Drug: Placebo
37 Unknown  HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Behavioral: Education
38 Unknown  Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)
Conditions: Rheumatoid Arthritis;   Systemic Lupus Erythematosus
Intervention:
39 Unknown  Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)
Condition: Systemic Lupus Erythematosus
Intervention: Procedure: Immunoablation and Autologous Hematopoietic Stem Cell Transplantation
40 Not yet recruiting A Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses of BIIB059 in Healthy Volunteers and Subjects With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus;   Healthy
Interventions: Drug: BIIB059;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years